Clinicopathological analysis of papillary thyroid cancer with PIK3CA alterations in a Middle Eastern population.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Journal of Clinical Endocrinology and Metabolism

• Publication date

  2008-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1210/JC.2007-1717PMID 18000091
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Estrogen receptor alpha (ESR1) gene amplification is frequent in breast cancer

  2007cited by this paper
• Targeting BRAF in thyroid cancer

  2007cited by this paper
• PIK3CA mutations are mutually exclusive with PTEN loss in diffuse large B-cell lymphoma

  2007cited by this paper
• High prevalence and mutual exclusivity of genetic alterations in the phosphatidylinositol-3-kinase/akt pathway in thyroid tumors.

  2007influential reference
• Genome‐wide expression analysis of Middle Eastern papillary thyroid cancer reveals c‐MET as a novel target for cancer therapy

  2007cited by this paper
• Genetic Alterations and Their Relationship in the Phosphatidylinositol 3-Kinase/Akt Pathway in Thyroid Cancer

  2007cited by this paper
• Targeting BRAF in thyroid cancer

  2006cited by this paper
• Prevalence of Fragile Histidine Triad Expression in Tumors from Saudi Arabia: A Tissue Microarray Analysis

  2006cited by this paper
• Uncommon mutation, but common amplifications, of the PIK3CA gene in thyroid tumors.

  2005cited by this paper
• PIK3CA mutations correlate with hormone receptors, node metastasis, and ERBB2, and are mutually exclusive with PTEN loss in human breast carcinoma.

  2005cited by this paper
• BRAF mutation in thyroid cancer.

  2005influential reference
• Prognostic Factors in Papillary Thyroid Cancer: An Evaluation of 601 Consecutive Patients

  2005cited by this paper
• Mutant PIK3CA promotes cell growth and invasion of human cancer cells.

  2005cited by this paper
• BRAF mutation predicts a poorer clinical prognosis for papillary thyroid cancer.

  2005cited by this paper
• Role of phosphatidylinositol 3'-kinase/AKT pathway in diffuse large B-cell lymphoma survival.

  2005cited by this paper
• BRAF mutations are not a major event in post-Chernobyl childhood thyroid carcinomas.

  2004cited by this paper
• Alternative mutations of BRAF, RET and NTRK1 are associated with similar but distinct gene expression patterns in papillary thyroid cancer

  2004cited by this paper
• Low frequency of BRAFT1796A mutations in childhood thyroid carcinomas.

  2004cited by this paper
• Clinical implication of hot spot BRAF mutation, V599E, in papillary thyroid cancers.

  2003cited by this paper
• BRAF mutation in papillary thyroid carcinoma.

  2003cited by this paper
• Genomic DNA Extraction and PCR Amplification of Exon 15 of the BRAF Gene and Exons 1 and 2 of the NRAS Gene

  2003cited by this paper
• Specific pattern of RAS oncogene mutations in follicular thyroid tumors.

  2003cited by this paper
• BRAF mutations in papillary carcinomas of the thyroid

  2003cited by this paper
• High prevalence of BRAF mutations in thyroid cancer: genetic evidence for constitutive activation of the RET/PTC-RAS-BRAF signaling pathway in papillary thyroid carcinoma.

  2003cited by this paper
• BRAF mutations in thyroid tumors are restricted to papillary carcinomas and anaplastic or poorly differentiated carcinomas arising from papillary carcinomas.

  2003cited by this paper
• The phosphatidylinositol 3-Kinase–AKT pathway in human cancer

  2002cited by this paper
• Relative expression software tool (REST©) for group-wise comparison and statistical analysis of relative expression results in real-time PCR

  2002cited by this paper
• Constitutive activation of the 41-/43-kDa mitogen-activated protein kinase signaling pathway in human tumors

  1999cited by this paper
• Chromosome 8p deletions are associated with invasive tumor growth in urinary bladder cancer.

  1997cited by this paper
• Pathological tumor-node-metastasis (pTNM) staging for papillary and follicular thyroid carcinomas: a retrospective analysis of 700 patients.

  1997cited by this paper
• Phosphatidylinositol-3-OH kinase direct target of Ras

  1994cited by this paper
• Papillary thyroid carcinoma.

  1990cited by this paper

• Decoding the Mutational Hierarchy of Thyroid Cancer and Associated Signaling Pathways.

  2026cites this paper
• Papillary Thyroid Carcinoma With 5 Unique Point Mutations and Typical Behavior

  2025cites this paper
• Cancer research in Saudi Arabia: A cross-sectional mapping study of historical growth, thematic analysis, collaboration patterns, and future directions.

  2025cites this paper
• Radioactive iodine refractoriness in Middle Eastern differentiated thyroid cancer: clinical outcome and risk factor analysis

  2024cites this paper
• Whole Exome-Wide Association Identifies Rare Variants in APC Associated with High-Risk Colorectal Cancer in the Middle East

  2024cites this paper
• Whole Exome-Wide Association Identifies Rare Variants in GALNT9 Associated with Middle Eastern Papillary Thyroid Carcinoma Risk

  2023cites this paper
• PIK3CA mutations in breast cancer: A Tunisian series

  2023cites this paper
• PALB2 germline mutations in a large cohort of Middle Eastern breast-ovarian cancer patients

  2023cites this paper
• Tyrosine Kinase Inhibitors for Radioactive Iodine Refractory Differentiated Thyroid Cancer

  2023influential citation
• Predictive risk factors for distant metastasis in pediatric differentiated thyroid cancer from Saudi Arabia

  2023cites this paper
• Will metformin use lead to a decreased risk of thyroid cancer? A systematic review and meta-analyses

  2023cites this paper
• Overexpression of the pro‐protein convertase furin predicts prognosis and promotes papillary thyroid carcinoma progression and metastasis through RAF/MEK signaling

  2023cites this paper
• Rare distant metastases to pancreas, liver, and lung as initial presentation of mixed tall cell and columnar cell variants of papillary thyroid cancer

  2022cites this paper
• Thyroid cancer incidence in the United Arab Emirates: a retrospective study on association with age and gender

  2022cites this paper
• PIK3CA mutations in the endocrine organs

  2022cites this paper
• Decrypting a path based approach for identifying the interplay between PI3K and GSK3 signaling cascade from the perspective of cancer

  2022cites this paper
• Mutational status may supersede tumor size in predicting the presence of aggressive pathologic features in well differentiated thyroid cancer

  2022cites this paper
• Prevalence of Lynch Syndrome in Middle Eastern Women with Mismatch Repair Deficient Ovarian Cancer

  2022cites this paper
• Lymph node ratio is superior to AJCC N stage for predicting recurrence in papillary thyroid carcinoma

  2022cites this paper
• Burden of thyroid cancer in North Africa and Middle East 1990–2019

  2022cites this paper
• Lynch Syndrome Identification in Saudi Cohort of Endometrial Cancer Patients Screened by Universal Approach

  2022cites this paper
• Prevalence of germline TP53 mutation among early onset middle eastern breast cancer patients

  2021cites this paper
• 44 Treatment of Advanced Thyroid Cancer: The Era of Targeted Modalities

  2021cites this paper
• PD-L1 Is an Independent Prognostic Marker in Middle Eastern PTC and Its Expression Is Upregulated by BRAFV600E Mutation

  2021cites this paper
• SYT12 is a novel oncogene that promotes thyroid carcinoma progression and metastasis

  2021cites this paper
• Analysis of the risk factors for central lymph node metastasis of cN0 papillary thyroid microcarcinoma: A retrospective study.

  2021cites this paper
• Relationship between TSHR, BRAF and PIK3CA gene copy number variations and thyroid nodules

  2021cites this paper
• PD-L1 Expression Is Associated with Deficient Mismatch Repair and Poor Prognosis in Middle Eastern Colorectal Cancers

  2021cites this paper
• Recurrent Somatic MAP2K1 Mutations in Papillary Thyroid Cancer and Colorectal Cancer

  2021cites this paper
• PSD3 is an oncogene that promotes proliferation, migration, invasion, and G1/S transition while inhibits apoptotic in papillary thyroid cancer

  2021cites this paper
• POLE and POLD1 germline exonuclease domain pathogenic variants, a rare event in colorectal cancer from the Middle East

  2020cites this paper
• POLE and POLD1 pathogenic variants in proofreading domain in papillary thyroid cancer Running title: POLE and POLD1 mutations in PTC Keywords: papillary thyroid cancer, IHC, pathogenic variants, POLE, POLD1 Word count: 3177

  2020cites this paper
• Effects of the MTOR and AKT1 genes polymorphisms on papillary thyroid cancer development

  2020cites this paper
• Akt1 genetic variants confer increased susceptibility to thyroid cancer

  2020cites this paper
• Prevalence of BRAFV600E mutation in Asian series of papillary thyroid carcinoma-a contemporary systematic review.

  2020cites this paper
• Annual Hazard Rate of Recurrence in Middle Eastern Papillary Thyroid Cancer over a Long-Term Follow-Up

  2020cites this paper
• Prognostic Significance of COX-2 Overexpression in BRAF-Mutated Middle Eastern Papillary Thyroid Carcinoma

  2020cites this paper
• Predictive Factors for Occult Bilateral Papillary Thyroid Carcinoma.

  2020cites this paper
• CLINICAL AND TRANSLATIONAL CHALLENGES IN THYROID CANCERS.

  2020cites this paper
• Scavenger receptor class A, member 5 is associated with thyroid cancer cell lines progression via epithelial‐mesenchymal transition

  2020cites this paper
• The Molecular Landscape of Hürthle Cell Thyroid Cancer Is Associated with Altered Mitochondrial Function—A Comprehensive Review

  2020cites this paper
• BRAF and KRAS mutations in papillary thyroid carcinoma in the United Arab Emirates

  2020cites this paper
• Stimulation of endothelial progenitor cells by microRNA-31a-5p to induce endothelialization in an aneurysm neck after coil embolization by modulating the Axin1-mediated β-catenin/vascular endothelial growth factor pathway.

  2020cites this paper
• KCNN4 is a diagnostic and prognostic biomarker that promotes papillary thyroid cancer progression

  2020cites this paper
• POLE and POLD1 pathogenic variants in the proofreading domain in papillary thyroid cancer

  2020cites this paper
• Molecular aberrations and signaling cascades implicated in the pathogenesis of anaplastic thyroid cancer.

  2019cites this paper
• Coding Molecular Determinants of Thyroid Cancer Development and Progression.

  2019cites this paper
• Anti-Tumor Activity and Safety of Multikinase Inhibitors in Advanced and/or Metastatic Thyroid Cancer: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials

  2019cites this paper
• Germline POLE and POLD1 proofreading domain mutations in endometrial carcinoma from Middle Eastern region

  2019cites this paper
• PIK3CA Gene Mutations in Solid Malignancies: Association with Clinicopathological Parameters and Prognosis

  2019cites this paper
• Downregulation of CDH16 in Papillary Thyroid Cancer and Its Potential Molecular Mechanism Analysed by qRT-PCR, TCGA and in silico Analysis

  2019cites this paper
• CMAR_A_229631 10719..10729

  2019cites this paper
• RAS-mediated oncogenic signaling pathways in human malignancies.

  2019cites this paper
• Risk factors for cervical lymph node metastasis in papillary thyroid microcarcinoma: a study of 1,587 patients

  2019cites this paper
• Systems Biology Approaches to Investigate Genetic and Epigenetic Molecular Progression Mechanisms for Identifying Gene Expression Signatures in Papillary Thyroid Cancer

  2019cites this paper
• GPCR-mediated PI3K pathway mutations in pediatric and adult thyroid cancer

  2019cites this paper
• Molecular markers prognosticate the aggressiveness of papillary thyroid cancer

  2019cites this paper
• E-cadherin expression is associated with susceptibility and clinicopathological characteristics of thyroid cancer

  2019cites this paper
• A multivariable model of BRAFV600E and ultrasonographic features for predicting the risk of central lymph node metastasis in cN0 papillary thyroid microcarcinoma

  2019cites this paper
• Targeted Treatment Options of Recurrent Radioactive Iodine Refractory Hürthle Cell Cancer

  2019cites this paper
• Growth‐associated protein 43 promotes thyroid cancer cell lines progression via epithelial‐mesenchymal transition

  2019cites this paper
• Genetic Alterations in Anaplastic Thyroid Carcinoma

  2019cites this paper
• Genetic and epigenetic alteration in thyroid cancer: review article

  2018cites this paper
• A somatic mutation of RasGRP3 decreases Na+/I- symporter expression in metastases of radioactive iodine-refractory thyroid cancer by stimulating the Akt signaling pathway.

  2018cites this paper
• Integrated analysis of long noncoding RNA interactions reveals the potential role in progression of human papillary thyroid cancer

  2018cites this paper
• BRAF mutation in papillary thyroid cancer—Prevalence and clinical correlation in a South‐East Asian cohort

  2018cites this paper
• Thyroid cancers of follicular origin in a genomic light: in-depth overview of common and unique molecular marker candidates

  2018cites this paper
• A somatic mutation of RasGRP 3 decreases Na + / I-symporter expression in metastases of radioactive iodine-refractory thyroid cancer by stimulating the Akt signaling pathway

  2018cites this paper
• Single Point Mutations in Pediatric Differentiated Thyroid Cancer

  2017influential citation
• Somatic mutation profiling of hobnail variant of papillary thyroid carcinoma.

  2017cites this paper
• Expanding the spectrum of germline variants in cancer

  2017cites this paper
• Meta-analysis of promoter methylation in eight tumor-suppressor genes and its association with the risk of thyroid cancer

  2017cites this paper
• Role of molecular markers to predict distant metastasis in papillary thyroid carcinoma: Promising value of TERT promoter mutations and insignificant role of BRAF mutations—a meta-analysis

  2017cites this paper
• Oncogenes, mitochondrial metabolism, and quality control in differentiated thyroid cancer

  2017cites this paper
• Molecular Pathology of Anaplastic Thyroid Carcinomas: A Retrospective Study of 144 Cases

  2017influential citation
• Hobnail Variant of Papillary Thyroid Carcinoma: a Literature Review

  2017cites this paper
• Differential Clinicopathological Risk and Prognosis of Major Papillary Thyroid Cancer Variants.

  2016cites this paper
• Significance of the BRAF mRNA Expression Level in Papillary Thyroid Carcinoma: An Analysis of The Cancer Genome Atlas Data

  2016cites this paper
• Specific gene patterns and molecular pathways related to human carcinogenesis in different populations among various geographic locations

  2016cites this paper
• Classical V600E and other non-hotspot BRAF mutations in adult differentiated thyroid cancer

  2016cites this paper
• Molecular mechanisms in differentiated thyroid cancer.

  2016cites this paper
• Signaling Pathways in Thyroid Cancer and Their Therapeutic Implications

  2016cites this paper
• Associations between BRAFV600E and prognostic factors and poor outcomes in papillary thyroid carcinoma: a meta-analysis

  2016cites this paper
• Identification of novel BRCA founder mutations in Middle Eastern breast cancer patients using capture and Sanger sequencing analysis

  2016cites this paper
• Clinicopathological significance of BRAFV 600 E mutation in Uyghur Chinese patients with papillary thyroid carcinoma

  2016cites this paper
• Prevalence of BRAF Mutation in Papillary Thyroid Cancer REVIEW / DERLEME

  2016cites this paper
• BRAF mutation in papillary thyroid cancer : a meta-analysis

  2016cites this paper
• Spotlight on lenvatinib in the treatment of thyroid cancer: patient selection and perspectives

  2016influential citation
• Shifting patterns of genomic variation in the somatic evolution of papillary thyroid carcinoma

  2016cites this paper
• Reply to specific gene patterns and molecular pathways related to human carcinogenesis in different populations among various geographic locations

  2016cites this paper
• Treatment of advanced thyroid cancer with targeted therapies: ten years of experience.

  2016cites this paper
• Spotlight on lenvatinib in the treatment of thyroid cancer: patient selection and perspectives

  2016influential citation
• Genomic Profiling of Thyroid Cancer Reveals a Role for Thyroglobulin in Metastasis.

  2016cites this paper
• Association between BRAF and RAS mutations, and RET rearrangements and the clinical features of papillary thyroid cancer.

  2015cites this paper
• Original Article Association between BRAF and RAS mutations, and RET rearrangements and the clinical features of papillary thyroid cancer

  2015cites this paper
• ALK alteration is a frequent event in aggressive breast cancers

  2015cites this paper
• Somatic amplifications and deletions in genome of papillary thyroid carcinomas

  2015cites this paper
• BRAF mutation in fine‐needle aspiration specimens as a potential predictor for persistence/recurrence in patients with classical papillary thyroid carcinoma larger than 10 mm at a BRAF mutation prevalent area

  2015cites this paper
• Differentiated thyroid cancer: focus on emerging treatments for radioactive iodine-refractory patients.

  2015cites this paper
• Prevalence of Lynch syndrome in a Middle Eastern population with colorectal cancer

  2015cites this paper